Schonfeld Strategic Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.25M Buy
2025
Q1
$644K Sell
2024
Q4
$22.8M Sell
2024
Q3
$25.1M Sell
2024
Q2
$29.3M Buy
2024
Q1
$6.33M Buy
2023
Q4
$2.39M Sell
2023
Q3
$8.24M Buy
2023
Q2
Sell
2023
Q1
$1.19M Buy
2022
Q1
Sell
2021
Q4
$528K Sell
2021
Q3
$453K Sell
2021
Q2
$411K Buy